Q: Good morning Peter and Team,
Thanks for your answer to my question about HCG. I recently came across this article: http://www.theglobeandmail.com/globe-investor/investment-ideas/big-bank-alternative-equitable-is-good-value-and-growing/article25486861/
In the article, there are two paragraphs that stood out for me:
National Bank Financial analyst Shuba Khan said he doesn’t have any concerns about Equitable Group’s originations in light of Home Capital’s announcement.
“The issues that Home Capital highlighted appear to be company-specific,” said Mr. Khan, who has an “outperform” (similar to “buy”) and $71 target on Equitable Group.
5i is of the opinion that Home Capital's severe price decline is industry related. I do trust your insight, but am having difficulty reconciling the fact that EQB's stock hasn't suffered nearly as much, and would appreciate your comments.
Thanks for your answer to my question about HCG. I recently came across this article: http://www.theglobeandmail.com/globe-investor/investment-ideas/big-bank-alternative-equitable-is-good-value-and-growing/article25486861/
In the article, there are two paragraphs that stood out for me:
National Bank Financial analyst Shuba Khan said he doesn’t have any concerns about Equitable Group’s originations in light of Home Capital’s announcement.
“The issues that Home Capital highlighted appear to be company-specific,” said Mr. Khan, who has an “outperform” (similar to “buy”) and $71 target on Equitable Group.
5i is of the opinion that Home Capital's severe price decline is industry related. I do trust your insight, but am having difficulty reconciling the fact that EQB's stock hasn't suffered nearly as much, and would appreciate your comments.